Cycle Pharmaceuticals Launches PHYRAGO Tablets in US for Oncology
Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in partnership with Handa Therapeutics, LLC, and will be exclusively available through...